[HTML][HTML] Treatment and outcome of patients with metastatic NSCLC: a retrospective institution analysis of 493 patients

N Reinmuth, N Payer, T Muley, H Hoffmann… - Respiratory …, 2013 - Springer
Background Most patients with metastatic non-small cell lung cancer (NSCLC) will face
treatment with systemic therapy. Current clinical studies are demonstrating improvements in …

[PDF][PDF] Treatment and outcome of patients with metastatic NSCLC: a retrospective institution analysis of 493 patients

N Reinmuth, N Payer, T Muley, H Hoffmann, FJF Herth… - 2013 - researchgate.net
Background: Most patients with metastatic non-small cell lung cancer (NSCLC) will face
treatment with systemic therapy. Current clinical studies are demonstrating improvements in …

Treatment and outcome of patients with metastatic NSCLC: a retrospective institution analysis of 493 patients.

N Reinmuth, N Payer, T Muley… - Respiratory …, 2013 - search.ebscohost.com
Background: Most patients with metastatic non-small cell lung cancer (NSCLC) will face
treatment with systemic therapy. Current clinical studies are demonstrating improvements in …

[PDF][PDF] Treatment and outcome of patients with metastatic NSCLC: a retrospective institution analysis of 493 patients

N Reinmuth, N Payer, T Muley, H Hoffmann, FJF Herth… - 2013 - cyberleninka.org
Background: Most patients with metastatic non-small cell lung cancer (NSCLC) will face
treatment with systemic therapy. Current clinical studies are demonstrating improvements in …

Treatment and outcome of patients with metastatic NSCLC: a retrospective institution analysis of 493 patients

N Reinmuth, N Payer, T Muley, H Hoffmann… - Respiratory …, 2013 - go.gale.com
Background Most patients with metastatic non-small cell lung cancer (NSCLC) will face
treatment with systemic therapy. Current clinical studies are demonstrating improvements in …

[PDF][PDF] Treatment and outcome of patients with metastatic NSCLC: a retrospective institution analysis of 493 patients

N Reinmuth, N Payer, T Muley, H Hoffmann, FJF Herth… - 2013 - Citeseer
Background: Most patients with metastatic non-small cell lung cancer (NSCLC) will face
treatment with systemic therapy. Current clinical studies are demonstrating improvements in …

[HTML][HTML] Treatment and outcome of patients with metastatic NSCLC: a retrospective institution analysis of 493 patients

N Reinmuth, N Payer, T Muley… - Respiratory …, 2013 - respiratory-research.biomedcentral …
Most patients with metastatic non-small cell lung cancer (NSCLC) will face treatment with
systemic therapy. Current clinical studies are demonstrating improvements in chemotherapy …

[HTML][HTML] Treatment and outcome of patients with metastatic NSCLC: a retrospective institution analysis of 493 patients

N Reinmuth, N Payer, T Muley, H Hoffmann… - Respiratory …, 2013 - ncbi.nlm.nih.gov
Background Most patients with metastatic non-small cell lung cancer (NSCLC) will face
treatment with systemic therapy. Current clinical studies are demonstrating improvements in …

[引用][C] Treatment and outcome of patients with metastatic NSCLC: a retrospective institution analysis of 493 patients

N Reinmuth, N Payer, T Muley, H Hoffmann… - Respiratory …, 2013 - cir.nii.ac.jp
Treatment and outcome of patients with metastatic NSCLC: a retrospective institution analysis
of 493 patients | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

Treatment and outcome of patients with metastatic NSCLC: a retrospective institution analysis of 493 patients.

N Reinmuth, N Payer, T Muley, H Hoffmann… - Respiratory …, 2013 - europepmc.org
Background Most patients with metastatic non-small cell lung cancer (NSCLC) will face
treatment with systemic therapy. Current clinical studies are demonstrating improvements in …